TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)

Q: What does CUSIP 881624209 represent in this 13F holders report?

CUSIP 881624209 is the security identifier for TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in Q1 2022?

420 institutional investors reported TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share for Q1 2022. Use the holders table for investor-level position and value details.

CUSIP: 881624209

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Ordinary Shares, par value NIS 0.01 per share
Total 13F shares: 514,571,916
Total 13F value: $4,831,771,215
Share change: -4,148,887
Put/Call ratio: 95%
SEC-reported price per share: $9.39
Number of holders: 420
Value change: +$15,212,208
Number of buys: 173
Number of sells: 157
Shares outstanding: 1,148,777,709

Security key

881624209

Report period

Q1 2022

Institutions

420

Top holders

TEVA full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2022 Previous quarter: Q4 2021 TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings TEVA PHARMACEUTICAL INDUSTRIES LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 881624209

Newer quarter: Q2 2022 Previous quarter: Q4 2021

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Capital Research Global I...

Disclosed value leader

Capital Research Global I...

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Comparable ownership Top 5

Capital Research Global Investors 12%

BlackRock Finance, Inc. 3.5%

ABRAMS CAPITAL MANAGEMENT, L.P. 2.1%

MENORA MIVTACHIM HOLDINGS LTD. 2%

Migdal Insurance & Financial Hold... 1.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Capital Research Global Investors	13F Company 13F	12%	$1,060,109,000 132,350,750 shares	—	31 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	3.5%	$321,634,000 40,153,902 shares	—	31 Dec 2021
ABRAMS CAPITAL MANAGEMENT, L.P.	13F Company 13F	2.1%	$192,611,000 24,046,356 shares	—	31 Dec 2021
MENORA MIVTACHIM HOLDINGS LTD.	13F Company 13F	2%	$184,248,000 23,002,282 shares	—	31 Dec 2021
Migdal Insurance & Financial Holdings Ltd.	13F Company 13F	1.8%	$167,129,000 20,864,900 shares	—	31 Dec 2021
Clal Insurance Enterprises Holdings Ltd	13F Company 13F	1.5%	$138,205,000 17,538,566 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

420

514,571,916

Rows available

420

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

404

Q1 2022 holders

420

Holder diff

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 value	Q1 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend